Načítá se...
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
OBJECTIVE: The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 polymorphism and endometrial cancer risk reported conflicting results. We performed...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029393/ https://ncbi.nlm.nih.gov/pubmed/24423195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-85 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|